About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Evidence-Based Ophthalmology
›
top-articles
Evidence-Based Ophthalmology
0.0
(top 100%)
impact factor
490
(top 50%)
papers
213
(top 50%)
citations
5
(top 50%)
h
-index
0.0
(top 100%)
impact factor
553
all documents
232
doc citations
9
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
THE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF INTRAOCULAR 90Sr BRACHYTHERAPY/INTRAVITREAL VEGF INHIBITOR FOR NEOVASCULAR MACULAR DEGENERATION
Evidence-Based Ophthalmology
2009
20
2
FALLS AND HEALTH STATUS IN ELDERLY WOMEN FOLLOWING FIRST EYE CATARACT SURGERY: A RANDOMIZED CONTROLLED TRIAL
Evidence-Based Ophthalmology
2005
10
3
VALUE-BASED MEDICINE'S COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSES
Evidence-Based Ophthalmology
2011
10
4
THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE: THE JNC REPORT
Evidence-Based Ophthalmology
2006
6
5
THE RESTORE STUDY
Evidence-Based Ophthalmology
2011
6
6
RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND GEOGRAPHIC ATROPHY IN THE COMPLICATIONS OF AGE-RELATED MACULAR DEGENERATION PREVENTION TRIAL
Evidence-Based Ophthalmology
2009
6
7
COMPARATIVE EFFECTIVENESS AND TRANSLATIONAL MEDICINE
Evidence-Based Ophthalmology
2008
5
8
CLINICAL CHARACTERISTICS OF HYDROXYCHLOROQUINE RETINOPATHY
Evidence-Based Ophthalmology
2011
5
9
TREATMENT OF POSTERIOR UVEITIS WITH A FLUOCINOLONE ACETONIDE IMPLANT
Evidence-Based Ophthalmology
2009
5
10
PUBLISHED INTERNATIONAL CLASSIFICATION OF RETINOBLASTOMA (ICRB) DEFINITIONS CONTAIN INCONSISTENCIES: AN ANALYSIS OF IMPACT
Evidence-Based Ophthalmology
2009
4
11
OUTBREAK OF ACQUIRED OCULAR TOXOPLASMOSIS INVOLVING 248 PATIENTS
Evidence-Based Ophthalmology
2010
4
12
RANDOMIZED TRIAL EVALUATING RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER OR TRIAMCINOLONE PLUS PROMPT LASER FOR DIABETIC MACULAR EDEMA
Evidence-Based Ophthalmology
2010
4
13
VALUE-BASED MEDICINE, COST-UTILITY ANALYSIS
Evidence-Based Ophthalmology
2009
4
14
PHYSICIANS AND NURSES ARE ECONOMIC VALUE PRODUCERS
Evidence-Based Ophthalmology
2006
4
15
THE RELATIONSHIP OF DIETARY CAROTENOID AND VITAMIN A, E, AND C INTAKE WITH AGE-RELATED MACULAR DEGENERATION IN A CASE-CONTROL STUDY AREDS REPORT NO. 22
Evidence-Based Ophthalmology
2008
3
16
PREVALENCE OF DIABETIC RETINOPATHY IN INDIA: SANKARA NETHRALAYA DIABETIC RETINOPATHY EPIDEMIOLOGY AND MOLECULAR GENETICS STUDY REPORT 2
Evidence-Based Ophthalmology
2009
3
17
TOPICAL CYCLOSPORINE (RESTASIS) COST-UTILITY ANALYSIS
Evidence-Based Ophthalmology
2009
3
18
PRIMARY END POINT (SIX MONTHS) RESULTS OF THE RANIBIZUMAB FOR EDEMA OF THE MACULA IN DIABETES (READ-2) STUDY
Evidence-Based Ophthalmology
2010
3
19
A RANDOMIZED TRIAL COMPARING THE EFFICACY AND SAFETY OF INTRAVITREAL TRIAMCINOLONE WITH STANDARD CARE TO TREAT VISION LOSS ASSOCIATED WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
Evidence-Based Ophthalmology
2010
3
20
WHAT'S IN STORE?
Evidence-Based Ophthalmology
2011
3
21
CENTRAL RETINAL ARTERY OCCLUSION
Evidence-Based Ophthalmology
2011
3
22
FLUOCINOLONE ACETONIDE IMPLANT (RETISERT) FOR NONINFECTIOUS POSTERIOR UVEITIS: THIRTY-FOUR–WEEK RESULTS OF A MULTICENTER RANDOMIZED CLINICAL STUDY
Evidence-Based Ophthalmology
2006
3
23
RANDOMIZED CONTROLLED STUDY OF AN INTRAVITREOUS DEXAMETHASONE DRUG DELIVERY SYSTEM IN PATIENTS WITH PERSISTENT MACULAR EDEMA
Evidence-Based Ophthalmology
2007
3
24
VALUE-BASED MEDICINE, COST-UTILITY ANALYSIS
Evidence-Based Ophthalmology
2008
3
25
THE BOSTON TYPE 1 KERATOPROSTHESIS: IMPROVING OUTCOMES AND EXPANDING INDICATIONS
Evidence-Based Ophthalmology
2009
3
26
COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSES
Evidence-Based Ophthalmology
2010
3
27
THE COMS RANDOMIZED TRIAL OF IODINE 125 BRACHYTHERAPY FOR CHOROIDAL MELANOMA V. TWELVE-YEAR MORTALITY RATES AND PROGNOSTIC FACTORS: COMS REPORT NO. 28
Evidence-Based Ophthalmology
2007
2
28
EDITORIAL: MADE TO ORDER
Evidence-Based Ophthalmology
2008
2
29
RISK OF ADVANCED AGE-RELATED MACULAR DEGENERATION AFTER CATARACT SURGERY IN THE AGE-RELATED EYE DISEASE STUDY: AREDS REPORT 25
Evidence-Based Ophthalmology
2009
2
30
A RANDOMIZED, MASKED COMPARISON OF TOPICAL KETOROLAC 0.4% PLUS STEROID VERSUS STEROID ALONE IN LOW-RISK CATARACT SURGERY PATIENTS
Evidence-Based Ophthalmology
2009
2
31
PATCHING VS ATROPINE TO TREAT AMBLYOPIA IN CHILDREN AGED 7 TO 12 YEARS
Evidence-Based Ophthalmology
2009
2
32
A VARIABLE-DOSING REGIMEN WITH INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: YEAR 2 OF THE PRONTO STUDY
Evidence-Based Ophthalmology
2010
2
33
A RANDOMIZED TRIAL COMPARING THE EFFICACY AND SAFETY OF INTRAVITREAL TRIAMCINOLONE WITH OBSERVATION TO TREAT VISION LOSS ASSOCIATED WITH MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION THE STANDARD CARE VERSUS CORTICOSTEROID FOR RETINAL VEIN OCCLUSION (SCORE) STUDY REPORT 5
Evidence-Based Ophthalmology
2010
2
34
THE 25-YEAR INCIDENCE OF VISUAL IMPAIRMENT IN TYPE 1 DIABETES MELLITUS
Evidence-Based Ophthalmology
2011
2
35
YAG LASER PERIPHERAL IRIDOTOMY FOR THE PREVENTION OF PIGMENT DISPERSION GLAUCOMA
Evidence-Based Ophthalmology
2011
2
36
NON-STEROIDAL ANTI-INFLAMMATORY AGENTS FOR CYSTOID MACULAR EDEMA FOLLOWING CATARACT SURGERY: A SYSTEMATIC REVIEW
Evidence-Based Ophthalmology
2006
2
37
COGNITIVE IMPAIRMENT IN THE AGE-RELATED EYE DISEASE STUDY
Evidence-Based Ophthalmology
2006
2
38
DETECTION OF EARLY HYDROXYCHLOROQUINE RETINAL TOXICITY ENHANCED BY RING RATIO ANALYSIS OF MULTIFOCAL ELECTRORETINOGRAPHY
Evidence-Based Ophthalmology
2008
2
39
CHOROIDAL NEVUS TRANSFORMATION INTO MELANOMA
Evidence-Based Ophthalmology
2010
2
40
VALUE-BASED MEDICINE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSES
Evidence-Based Ophthalmology
2011
2
41
A SYSTEM FOR PREOPERATIVE STRATIFICATION OF CATARACT PATIENTS ACCORDING TO RISK OF INTRAOPERATIVE COMPLICATIONS: A PROSPECTIVE ANALYSIS OF 1441 CASES
Evidence-Based Ophthalmology
2005
1
42
DIABETIC RETINOPATHY IN A MULTI-ETHNIC COHORT IN THE UNITED STATES
Evidence-Based Ophthalmology
2006
1
43
RANIBIZUMAB COMBINED WITH VERTEPORFIN PHOTODYNAMIC THERAPY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: YEAR 1 RESULTS OF THE FOCUS STUDY
Evidence-Based Ophthalmology
2007
1
44
A PROSPECTIVE RANDOMIZED TRIAL OF DIFFERENT DOSES OF INTRAVITREAL TRIAMCINOLONE FOR DIABETIC MACULAR EDEMA
Evidence-Based Ophthalmology
2007
1
45
IMPACT OF THE DESCEMET MEMBRANE PERFORATION ON SURGICAL OUTCOMES AFTER DEEP LAMELLAR KERATOPLASTY
Evidence-Based Ophthalmology
2007
1
46
EFFECT OF RUBOXISTAURIN IN PATIENTS WITH DIABETIC MACULAR EDEMA: THIRTY-MONTH RESULTS OF THE RANDOMIZED PKC-DMES CLINICAL TRIAL
Evidence-Based Ophthalmology
2007
1
47
MIDLIFE RISK FACTORS AND HEALTHY SURVIVAL IN MEN
Evidence-Based Ophthalmology
2007
1
48
REVIEW: SAMPLE SIZE CALCULATION
Evidence-Based Ophthalmology
2008
1
49
MANAGEMENT OF DIABETIC RETINOPATHY: A SYSTEMATIC REVIEW
Evidence-Based Ophthalmology
2008
1
50
C-REACTIVE PROTEIN LEVEL AND RISK OF AGING MACULA DISORDER
Evidence-Based Ophthalmology
2008
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.